 SOUTH SAN FRANCISCO, Calif., Sept. 01, 2022 GLOBE NEWSWIRE -- Sutro Biopharma, Inc. Sutro or the Company NASDAQ: STRO, a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates ADCs, today announced that Bill Newell, Chief Executive Officer, will present at the 2022 Wells Fargo Healthcare Conference on Friday, September 9, 2022, at 10:25 a.m. ET 7:25 a.m. PT in Boston. 